Concepedia

Keiji Yamagami

KY

Statistics

Publications

22

Citations

532

H-Index

15

Active since

1979

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Mitsubishi Chemical (Japan)

Nihon University

Hokkaido University

Kyoto Pharmaceutical Industries (Japan)

Keiji Yamagami is an author at Mitsubishi Tanabe Pharma Corporation specializing in life sciences, neuroscience, and neuropharmacology.

Publications per year

1979–2017

22

Publications

22

Nucleosides and nucleotides. 83. Design, synthesis, and antineoplastic activity of 2'-deoxy-2'-methylidenecytidine

Kenji Takenuki, Akira Matsuda, Takuma Sasaki et al. · Journal of Medicinal Chemistry · 1988 · 74 citations

, , +14

Decrement of muscarinic receptor-stimulated low-KMGTPase in striatum and hippocampus from the aged rat

Keiji Yamagami, James A. Joseph, G. S. Roth · Brain Research · 1992 · 49 citations

, , +12

Orally Active Neurotrophin-Enhancing Agent Protects Against Dysfunctions of the Peripheral Nerves in Hyperglycemic Animals

Bunpei Kakinoki, Sumito Sekimoto, Satoshi Yuki et al. · Diabetes · 2006 · 33 citations · Full text

, , +17

Area specific alterations in muscarinic stimulated low Km GTPase activity in aging and Alzheimer's disease: implications for altered signal transduction

Richelle Cutler, James A. Joseph, Keiji Yamagami et al. · Brain Research · 1994 · 32 citations

, , +16

2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 32 citations · Full text

, , +11

1–5 of 22